349
Views
20
CrossRef citations to date
0
Altmetric
Research Article

Metformin ameliorates acetaminophen-induced sub-acute toxicity via antioxidant property

, , , , , , & show all
Pages 52-60 | Received 04 Jul 2019, Accepted 10 Aug 2019, Published online: 02 Sep 2019

References

  • Aebi, H., et al., 1974. Heterogeneity of erythrocyte catalase II. Isolation and characterization of normal and variant erythrocyte catalase and their subunits. European Journal of Biochemistry, 48(1), 137–145.
  • Angulo, P. and Lindor, K.D., 2002. Treatment of non-alcoholic steatohepatitis. Best Practice & Research. Clinical Gastroenterology, 16(5), 797–810.
  • Bajt, M.L., et al., 2004. Acetaminophen-induced oxidant stress and cell injury in cultured mouse hepatocytes: protection by N-acetyl cysteine. Toxicological Sciences, 80(2), 343–349.
  • Barzilai, N., et al., 2016. Metformin as a tool to target aging. Cell Metabolism, 23(6), 1060–1065.
  • Benzie, I. F. and Strain, J. J., 1996. The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem, 239(1), 70–76.
  • Bergheim, I., et al., 2006. Metformin prevents alcohol-induced liver injury in the mouse: critical role of plasminogen activator inhibitor-1. Gastroenterology, 130(7), 2099–2112.
  • Bromer, M.Q. and Black, M., 2003. Acetaminophen hepatotoxicity. Clinics in Liver Disease, 7(2), 351–367.
  • Budnitz, D.S., Lovegrove, M.C., and Crosby, A.E., 2011. Emergency department visits for overdoses of acetaminophen-containing products. American Journal of Preventive Medicine, 40(6), 585–592.
  • Bugianesi, E., et al., 2004. Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment. Best Practice & Research Clinical Gastroenterology, 18(6), 1105–1116.
  • Buldak, L., et al., 2014. Metformin affects macrophages' phenotype and improves the activity of glutathione peroxidase, superoxide dismutase, catalase and decreases malondialdehyde concentration in a partially AMPK-independent manner in LPS-stimulated human monocytes/macrophages. Pharmacological Reports, 66(3), 418–429.
  • Cakatay, U. and Kayali, R., 2005. Plasma protein oxidation in aging rats after alpha-lipoic acid administration. Biogerontology, 6(2), 87–93.
  • Cameron, A.R., et al., 2018. Metformin selectively targets redox control of complex I energy transduction. Redox Biology, 14, 187–197.
  • Chaudhary, M.K., Singh, S., and Rizvi, S.I., 2017. Redox imbalance in a model of rat mimicking Hutchinson-Gilford progeria syndrome. Biochemical and Biophysical Research Communications, 491(2), 361–367.
  • Chukwunonso Obi, B., et al., 2016. Comparative study of the antioxidant effects of metformin, glibenclamide, and repaglinide in alloxan-induced diabetic rats. Journal of Diabetes Research, 2016, 1.
  • Dasgupta, B. and Chhipa, R.R., 2016. Evolving lessons on the complex role of AMPK in normal physiology and cancer. Trends in Pharmacological Sciences, 37(3), 192–206.
  • Du, K., et al., 2016. Editor's highlight: metformin protects against acetaminophen hepatotoxicity by attenuation of mitochondrial oxidant stress and dysfunction. Toxicological Sciences, 154(2), 214–226.
  • Ebada, M.E., 2018. Essential oils of green cumin and chamomile partially protect against acute acetaminophen hepatotoxicity in rats. Anais da Academia Brasileira de Ciências, 90(2 suppl 1), 2347–2358.
  • El Morsy, E.M. and Kamel, R., 2015. Protective effect of artichoke leaf extract against paracetamol-induced hepatotoxicity in rats. Pharmaceutical Biology, 53(2), 167–173.
  • Eruslanov, E. and Kusmartsev, S., 2010. Identification of ROS using oxidized DCFDA and flow-cytometry. Methods in Molecular Biology (Clifton, N.J.), 594, 57–72.
  • Esteghamati, A., et al., 2013. Effects of metformin on markers of oxidative stress and antioxidant reserve in patients with newly diagnosed type 2 diabetes: a randomized clinical trial. Clinical Nutrition (Edinburgh, Scotland), 32(2), 179–185.
  • Foretz, M., et al., 2014. Metformin: from mechanisms of action to therapies. Cell Metabolism, 20(6), 953–966.
  • Garg, G., et al., 2017a. Antiaging effect of metformin on brain in naturally aged and accelerated senescence model of rat. Rejuvenation Research, 20(3), 173–182.
  • Garg, G., et al., 2017b. Metformin alleviates altered erythrocyte redox status during aging in rats. Rejuvenation Research, 20(1), 15–24.
  • Ghallab, A., 2018. Highlight report: necrosis-apoptosis conundrum of hepatocytes: mode of hepatocyte death after acetaminophen intoxication. EXCLI Journal, 17, 1191–1193.
  • Ghanem, C.I., et al., 2016. Acetaminophen from liver to brain: new insights into drug pharmacological action and toxicity. Pharmacological Research, 109, 119–131.
  • Griffin, S.J., Leaver, J.K., and Irving, G.J., 2017. Impact of metformin on cardiovascular disease: a meta-analysis of randomised trials among people with type 2 diabetes. Diabetologia, 60(9), 1620–1629.
  • Habig, W.H., Pabst, M.J., and Jakoby, W.B., 1974. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. The Journal of Biological Chemistry, 249(22), 7130–7139.
  • Hamzeh, M., et al., 2018. Atorvastatin mitigates cyclophosphamide-induced hepatotoxicity via suppression of oxidative stress and apoptosis in rat model. Research in Pharmaceutical Sciences, 13(5), 440–449.
  • Hasanein, P. and Sharifi, M., 2017. Effects of rosmarinic acid on acetaminophen-induced hepatotoxicity in male Wistar rats. Pharmaceutical Biology, 55(1), 1809–1816.
  • Hu, J.N., et al., 2019. Ginsenoside Rk1 ameliorates paracetamol-induced hepatotoxicity in mice through inhibition of inflammation, oxidative stress, nitrative stress and apoptosis. Journal of Ginseng Research, 43(1), 10–19.
  • Jaeschke, H., McGill, M.R., and Ramachandran, A., 2012. Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity. Drug Metabolism Reviews, 44(1), 88–106.
  • Kelly, B., et al., 2015. Metformin inhibits the production of reactive oxygen species from NADH:ubiquinone oxidoreductase to limit induction of interleukin-1beta (IL-1beta) and boosts interleukin-10 (IL-10) in lipopolysaccharide (LPS)-activated macrophages. Journal of Biological Chemistry, 290(33), 20348–20359.
  • Kim, Y.H., et al., 2015. Metformin ameliorates acetaminophen hepatotoxicity via Gadd45beta-dependent regulation of JNK signaling in mice. Journal of Hepatology, 63(1), 75–82.
  • Kisaoglu, A., et al., 2014. Damage induced by paracetamol compared with N-acetylcysteine. Journal of the Chinese Medical Association, 77(9), 463–468.
  • Kulkarni, S., 2011. Acute paracetamol toxicity—a case report. Indian Journal of Applied Research, 3(12), 466–468.
  • Li, Y., et al., 2013. Metformin in non-alcoholic fatty liver disease: a systematic review and meta-analysis. Biomedical Reports, 1(1), 57–64.
  • Lin, C.F., et al., 2013. Blockade of reactive oxygen species and Akt activation is critical for anti-inflammation and growth inhibition of metformin in phosphatase and tensin homolog-deficient RAW264.7 cells. Immunopharmacology and Immunotoxicology, 35(6), 669–677.
  • Malek, M., et al., 2013. Risk of cancer in diabetes: the effect of metformin. ISRN Endocrinology, 2013, 636927.
  • Manthripragada, A.D., et al., 2011. Characterization of acetaminophen overdose-related emergency department visits and hospitalizations in the United States. Pharmacoepidemiology and Drug Safety, 20(8), 819–826.
  • Markowicz-Piasecka, M., et al., 2017. Metformin—a future therapy for neurodegenerative diseases: theme: drug discovery, development and delivery in Alzheimer's disease guest editor: Davide Brambilla. Pharmaceutical Research, 34(12), 2614–2627.
  • Maruthur, N.M., et al., 2016. Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis. Annals of Internal Medicine, 164(11), 740–751.
  • McGill, M.R. and Jaeschke, H., 2013. Metabolism and disposition of acetaminophen: recent advances in relation to hepatotoxicity and diagnosis. Pharmaceutical Research, 30(9), 2174–2187.
  • Melmed, S., et al., 2016. Williams textbook of endocrinology. 13th ed. Philadelphia: Elsevier.
  • Meng, X.M., et al., 2017. Metformin improves the glucose and lipid metabolism via influencing the level of serum total bile acids in rats with streptozotocin-induced type 2 diabetes mellitus. European Review for Medical and Pharmacological Sciences, 21(9), 2232–2237.
  • Mihaylova, M.M. and Shaw, R.J., 2011. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nature Cell Biology, 13(9), 1016–1023.
  • Misra, H.P. and Fridovich, I., 1972. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. The Journal of Biological Chemistry, 247(10), 3170–3175.
  • Noeman, S.A., Hamooda, H.E., and Baalash, A.A., 2011. Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats. Diabetology & Metabolic Syndrome, 3(1), 17.
  • Noto, H., et al., 2012. Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis. PLoS One, 7(3), e33411.
  • Onken, B. and Driscoll, M., 2010. Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One, 5(1), e8758.
  • Rizvi, S.I., Jha, R., and Maurya, P.K., 2006. Erythrocyte plasma membrane redox system in human aging. Rejuvenation Research, 9(4), 470–474.
  • Saeedi Saravi, S.S., et al., 2016. The protective potential of metformin against acetaminophen-induced hepatotoxicity in BALB/C mice. Pharmaceutical Biology, 54(12), 2830–2837.
  • Saraswat, K., Kumar, R., and Rizvi, S.I., 2019. Glycolytic inhibitor 2-deoxy-D-glucose at chronic low dose mimics calorie restriction in rats through mitohormetic induction of reactive oxygen species. Rejuvenation Research. doi: https://doi.org/10.1089/rej.2018.2125.
  • Shanmugam, S., et al., 2017. Polyphenols rich Passiflora leschenaultii leaves modulating Farnesoid X Receptor and Pregnane X Receptor against paracetamol-induced hepatotoxicity in rats. Biomedicine & Pharmacotherapy, 88, 1114–1121.
  • Sid, B., Verrax, J., and Calderon, P.B., 2013. Role of AMPK activation in oxidative cell damage: implications for alcohol-induced liver disease. Biochemical Pharmacology, 86(2), 200–209.
  • Soliman, M.M., Abdo Nassan, M., and Ismail, T.A., 2014. Immunohistochemical and molecular study on the protective effect of curcumin against hepatic toxicity induced by paracetamol in Wistar rats. BMC Complementary and Alternative Medicine, 14(1), 457.
  • Tripathi, S.S., et al., 2019. Metformin protects red blood cells against rotenone induced oxidative stress and cytotoxicity. Archives of Physiology and Biochemistry, 1–10.
  • Uygun, A., et al., 2004. Metformin in the treatment of patients with non-alcoholic steatohepatitis. Alimentary Pharmacology and Therapeutics, 19(5), 537–544.
  • Wang, L., et al., 2016a. Nrf2-mediated liver protection by esculentoside A against acetaminophen toxicity through the AMPK/Akt/GSK3beta pathway. Free Radical Biology and Medicine, 101, 401–412.
  • Wang, N., et al., 2016b. Metformin improves lipid metabolism disorders through reducing the expression of microsomal triglyceride transfer protein in OLETF rats. Diabetes Research and Clinical Practice, 122, 170–178.
  • Wang, Z., et al., 2017. Caspase-mediated anti-apoptotic effect of ginsenoside Rg5, a main rare ginsenoside, on acetaminophen-induced hepatotoxicity in mice. Journal of Agricultural and Food Chemistry, 65(42), 9226–9236.
  • Wendel, A. and Feuerstein, S., 1981. Drug-induced lipid peroxidation in mice-I. Modulation by monooxygenase activity, glutathione and selenium status. Biochemical Pharmacology, 30(18), 2513–2520.
  • Woolbright, B.L. and Jaeschke, H., 2017. Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure. Journal of Hepatology, 66(4), 836–848.
  • Woudenberg-Vrenken, T.E., et al., 2013. Metformin protects rat hepatocytes against bile acid-induced apoptosis. PLoS One, 8(8), e71773.
  • Yapar, K., et al., 2007. Hepatoprotective effect of L-carnitine against acute acetaminophen toxicity in mice. Experimental and Toxicologic Pathology, 59(2), 121–128.
  • Yin, H., Xu, L., and Porter, N.A., 2011. Free radical lipid peroxidation: mechanisms and analysis. Chemical Reviews, 111(10), 5944–5972.
  • Yoon, E., et al., 2017. Acetaminophen-induced hepatotoxicity: a comprehensive update. Journal of Clinical and Translational Hepatology, 4(2), 131–142.
  • Yoshioka, H., et al., 2017. Suppressive effect of kamebakaurin on acetaminophen-induced hepastotoxicity by inhibiting lipid peroxidation and inflammatory response in mice. Pharmacological Reports, 69(5), 903–907.
  • Zang, M., et al., 2004. AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. Journal of Biological Chemistry, 279(46), 47898–47905.
  • Zhou, G., et al., 2001. Role of AMP-activated protein kinase in mechanism of metformin action. The Journal of Clinical Investigation, 108(8), 1167–1174.
  • Zi, F., et al., 2018. Metformin and cancer: an existing drug for cancer prevention and therapy. Oncology Letters, 15(1), 683–690.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.